Dr. Vessela Vassileva
Head of Research and Development
Dr. Vassileva has worked in research and innovation for more than 20 years, across the academic, regulatory and publishing sectors. She is passionate about translating innovative therapeutics and technologies into improved patient outcomes. Dr. Vassileva is a legacy member of the HEI team being a UofT graduate. Dr Vassileva is a consultant for HEI and the Environs Group
Dr. Vassileva completed her HonBSc in Human Biology, MSc in Cancer Genetics and Pathobiology, and PhD in Pharmaceutical Sciences at the University of Toronto, before embarking onto an exciting career in health innovation. Dr. Vassileva has worked at world-renowned academic institutions, including, Imperial College London, University College London, Queen Mary University London, and University of Toronto. She has also worked at the European Medicines Agency and at Nature Reviews Clinical Oncology.
Dr. Vassileva is a member of several professional groups, including the National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group, where she is involved in clinical and translational issues concerning radiation therapy, peer-review and the development of practice-changing trials. She is a Trustee of the Head and Neck Research Charity. Dr. Vassileva is on the Editorial Board of the European Journal of Nuclear Medicine and Molecular Imaging Research, and peer-reviewers for numerous scientific journals and research funding agencies, providing scientific advice to
scientists and clinicians worldwide.